Navigation Links
Waters and DAISO Sign Marketing Agreement for Bulk Process Chromatography Media

MILFORD, Mass. and OSAKA, Japan, Feb. 17 /PRNewswire/ -- Waters Corporation and DAISO CO., LTD. jointly announced today that they are entering into a collaborative agreement to globally market and supply DAISOGEL™ bulk packing materials for process chromatography. The combined purification expertise of both organizations will aid pharmaceutical and biopharmaceutical companies as they move from lab-scale purifications into pilot plant and process-scale manufacturing.

To simplify scaling-up purification methods, DAISOGEL™ columns are packed using Waters patented Optimum Bed Density (OBD™) Technology(1). OBD Technology enables analytical column performance and industry best lifetime in larger preparative columns. Scientists will save time by eliminating the need for subsequent method redevelopment as they increase in scale.

As drug manufacturers invest significant amounts of money to manufacture new drug substances, they need solid commitments from established high quality process bulk suppliers with a long track record for synthesizing chromatographic media for drug purification processes.

DAISO's comprehensive quality control system is based on ISO 9001 and has met the quality requirements of global pharmaceutical companies. DAISO also has a DMF (Drug Master File) on file with the U.S. Food and Drug Administration (FDA) for the DAISOGEL™ packing materials.

Whether they need gram quantity amounts or hundreds of kilograms of bulk media, contract manufacturing organizations, innovator pharmaceutical, biopharmaceutical, natural product, and generic pharmaceutical laboratories can find the media they need in the right quantity and quality from Waters Corporation.

DAISOGEL™ packing materials and packed HPLC columns are available from Waters.

For more information:

About DAISO ( )

DAISO provides a various range of products and technical services to such industries as pharmaceuticals, agrochemicals, electronics, machinery, textile and construction as a technology-oriented chemical company of Japan.

Providing high technology and high performance materials, DAISO contributes to global environmental conservation, industrial development and the improvement of living comfort and safety.

With revenue of 76.7 billion Japanese yen and 745 employees for the fiscal year ended March 31, 2009, DAISO is supplying a variety of high-quality products for global customers.

About Waters Corporation ( )

Waters Corporation creates business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.5 billion in 2009 and 5,200 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters, The Science of What's Possible and OBD are trademarks of Waters Corporation. DAISOGEL is a trademark of DAISO CO., LTD.

(1) US Patent Number 7,399,410 and UK Patent Number GB 2408 469

SOURCE Waters Corporation



SOURCE Waters Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Waters Ships First Units of SYNAPT G2 Mass Spectrometer
2. First ASMS Hites Award for Outstanding Research Publication Presented to Prof. Alison Ashcroft for Her Use of Waters Synapt HDMS System to Explore Protein Complexes
3. Waters Introduces New SYNAPT G2 with Greater Power, Versatility and Speed Than Any Other High-End Mass Spectrometer
4. Waters and University of Warwick Sign Research Agreement Designed to Foster Adoption of Novel MS Technologies
5. Waters Corporation Continues to Meet Todays Challenges for Improved Laboratory Operations with New Products at Pittcon 2009
6. USDA Boosts Food Safety Research with Purchase of Waters ACQUITY TQD System
7. XenoTech LLC Offers Drug Industry New Metabolite Profiling Services Following Acquisition of Waters Synapt HDMS System
8. Waters New ACQUITY UPLC Online Community Attracts More Than 1,200 Members in First Month
9. Waters Corporation Gives Boost to Clinical Research Programs at University of Sherbrooke Hospital
10. Waters Publishes Rapid and Specific Method of Detection for Melamine in Infant Formula and Liquid Milk, in Support of Chinas Ministry of Science and Technology
11. David H. Murdock Research Institute Taps Waters for Laboratory Technology
Post Your Comments:
(Date:11/25/2015)... , November 26, 2015 ... Biobanking Market 2016 - 2020 report analyzes that ... integrity and quality in long-term samples, minimizing manual ... cost-effectiveness. Automation minimizes manual errors such as mislabeling ... efficiency. Further, it plays a vital role in ...
(Date:11/25/2015)... Studies reveal the differences in species of bacteria ... for more effective treatment for one of the most commonly ... --> --> Gum disease is one ... relatively little was understood about the bacteria associated with it ... researchers from the WALTHAM Centre for Pet Nutrition together with ...
(Date:11/25/2015)... CITY , Nov. 25, 2015 /PRNewswire/ - Aeterna ... affirms that its business and prospects remain fundamentally ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation ... to completion following review of the final interim ... Phase 2 Primary Endpoint in men with heavily ...
(Date:11/25/2015)... 25, 2015 The Global ... a professional and in-depth study on the current ... (Logo: ) , The ... including definitions, classifications, applications and industry chain structure. ... international markets including development trends, competitive landscape analysis, ...
Breaking Biology Technology:
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
(Date:11/2/2015)... 2, 2015  SRI International has been awarded a ... development services to the National Cancer Institute (NCI) PREVENT ... scientific expertise, modern testing and support facilities, and analytical ... and toxicology studies to evaluate potential cancer prevention drugs. ... PREVENT Cancer Drug Development Program is an NCI-supported pipeline ...
(Date:10/29/2015)... Oct. 29, 2015  Connected health pioneer, Joseph ... explosion of technology-enabled health and wellness, and the business ... The Internet of Healthy Things . ... smartphones even existed, Dr. Kvedar, vice president, Connected Health, ... care delivery, moving care from the hospital or doctor,s ...
Breaking Biology News(10 mins):